Just recently, the Jupiter study hailed the statin Crestor as a new "cure" for people with elevated rates of CRP (C-Reactive Protein) and normal LDL cholesterol.
CRP is a marker for inflammation within the body, and it has been suggested that an elevated CRP is a risk factor for heart disease. What the media and the promoters of statin drugs don't tell you is that the risk reduction for the group taking Crestor in this study was minimal. Out of almost 18,000 subjects, the difference was about 50 deaths between the control and test group over the entire length of the study. That's less than a 1% absolute difference.
Considering the dangerous and often permanent side effects of statin drugs, and the fact that they cost the patients $3.50 a day, the fanfare about these result is totally overblown.
In addition, other studies have shown that a low carbohydrate diet and plain old, cheap magnesium supplements work much better to lower CRP and inflammation without the dangerous side effects.
Since its release, Crestor has been associated with an increase in the number of reports of rhabdomyolysis, a condition in which dying muscle cells release substances which cause secondary kidney damage. The FDA has yet to take action to remove this dangerous drug from the market.